Urinary Bladder Neoplasms: all 1,649 studies
Page 3 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer PatientsNot yet recruitingNCT06623162Phase 2
- A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder CancerRecruitingNCT06595446Not applicable
- Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder CancerRecruitingNCT06586255Phase 1
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)RecruitingNCT06571708Phase 2
- Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBCRecruitingNCT06567743Phase 2
- Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)RecruitingNCT06551233Phase 1
- HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADCRecruitingNCT06548529Not applicable
- The Impact of PDD During TURB for NMIBCNot yet recruitingNCT06548438Phase 4
- Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy PatientsEnrolling by invitationNCT06541821
- Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder CancersRecruitingNCT06537960Not applicable
- NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs TreatmentRecruitingNCT06537154Phase 2/3
- Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseRecruitingNCT06529822Phase 1
- Telehealth Intervention for Ostomy Self-ManagementRecruitingNCT06528990Phase 2
- Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder CancerNot yet recruitingNCT06528483Phase 2
- Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light ResectionRecruitingNCT06525571Phase 3
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionRecruitingNCT06503146Phase 2
- Modular Trial of sEphB4-HSA in EphrinB2-High Solid TumorsRecruitingNCT06493552Phase 2/3
- Intravenous Ascorbate Plus Gemcitabine/Carboplatin: a Novel and Cost-Effective Alternative with Evident Efficacy in Patients with Muscle Invasive Bladder CancerRecruitingNCT06493370Phase 2
- Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder CancerRecruitingNCT06488222Phase 2
- AI Detection of Bladder Tumors Under EndoscopyRecruitingNCT06474338
- Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder CancerRecruitingNCT06470282Phase 1/2
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Cancer Loyalty Card Study 2 (CLOCS-2)RecruitingNCT06447064
- An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGAvailableNCT06443944
- Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder CancerRecruitingNCT06441110Phase 3
- Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical CystectomyRecruitingNCT06427824Not applicable
- Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC PatientsRecruitingNCT06427291Phase 1
- FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder CancerRecruitingNCT06421142Not applicable
- Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)RecruitingNCT06416319Not applicable
- Prognostic Performance of a Chemogram in Patients With Bladder Cancer.RecruitingNCT06403202
- Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.RecruitingNCT06394869Not applicable
- Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder CancerRecruitingNCT06394570Phase 1/2
- Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder CancerRecruitingNCT06389019
- The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential TherapyRecruitingNCT06388720Phase 2
- To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2RecruitingNCT06378242Phase 1/2
- Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer PatientsNot yet recruitingNCT06374914
- Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial TranscriptomicsRecruitingNCT06373055
- Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial CarcinomaRecruitingNCT06364956Phase 1/2
- Multi-parametric MRI in Patients of Bladder CancerRecruitingNCT06362330
- Pre-operative Immuno-Nutrition in Radical CystectomyNot yet recruitingNCT06355518Not applicable
- Investigator Grant (IG) 2022 27746RecruitingNCT06341478Not applicable
- RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC PatientsRecruitingNCT06341400Phase 1/2
- Antitumor T Cell Responses in Patients With Bladder CancerNot yet recruitingNCT06334406
- HIVEC in Patients With Non-Muscle-Invasive Bladder CancerNot yet recruitingNCT06327932Phase 3
- Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerNot yet recruitingNCT06325423
- Cryoablation Versus BCG Instillation Therapy for High-risk NMIBCNot yet recruitingNCT06324058Not applicable
- Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial CancerRecruitingNCT06310759
- Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder CancerNot yet recruitingNCT06310369Phase 2
- Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.RecruitingNCT06289270
- The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral ResectionRecruitingNCT06287541Not applicable
- First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder TumoursRecruitingNCT06281080Not applicable
- Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based TherapyRecruitingNCT06263153Phase 2
- Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial CarcinomaRecruitingNCT06257017Phase 2
- A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder CancerNot yet recruitingNCT06255964Phase 1/2
- Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical CystectomyRecruitingNCT06253091Not applicable
- The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer PatientsRecruitingNCT06245759
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)RecruitingNCT06241755Phase 3
- Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived OrganoidsNot yet recruitingNCT06227065Phase 2
- Elastographic Analysis of Urothelial Bladder TumoursRecruitingNCT06225726
- Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)RecruitingNCT06218433Not applicable
- The Nephroprotective Effect of Metformin With Cisplatin in Bladder CancerRecruitingNCT06215976Phase 4
- Radiation Therapy in Unresectable Gall Bladder CancerRecruitingNCT06214572Phase 2/3
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBCRecruitingNCT06186414Phase 1
- PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder CancerRecruitingNCT06173349Phase 1
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Study on the Quality of Life and Pathological State in Patients Who Underwent Radical CystectomyRecruitingNCT06170177
- Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.RecruitingNCT06167356
- Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease FollowupNot yet recruitingNCT06153849
- Day-case Endourology; Patient ExperienceRecruitingNCT06152679
- Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric AssessmentsRecruitingNCT06138561
- Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical CystectomyRecruitingNCT06115434
- Bladder Bank (a Prospective Banking Study)RecruitingNCT06109857
- A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)RecruitingNCT06108492Phase 1
- Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder CancerRecruitingNCT06092450
- Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder CarcinomaRecruitingNCT06091124Phase 2
- A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder CancerRecruitingNCT06074484Phase 2
- Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder CancerRecruitingNCT06046469Not applicable
- A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving TrialRecruitingNCT06040762Not applicable
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy VolunteersNot yet recruitingNCT06034015Phase 1
- Medical Imaging in Bladder Tumors by MRIRecruitingNCT06033040
- Safely Reduce Cystoscopic Evaluations for Hematuria PatientsRecruitingNCT06026189Not applicable
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.RecruitingNCT06022029Phase 1
- A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV InjectionRecruitingNCT06011954
- Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder CancerRecruitingNCT06009848Phase 2
- Exploring Engagement Dynamics Among Individuals Impacted by Bladder CancerNot yet recruitingNCT06009510
- [68Ga] NOTA-SGC8 in the Staging of Bladder CancerRecruitingNCT06005116Not applicable
- RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder CancerNot yet recruitingNCT05996952Phase 2
- Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder CancerRecruitingNCT05982561
- RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBCRecruitingNCT05979740Phase 2
- Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder CancerRecruitingNCT05975151Phase 2
- Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety MarginsRecruitingNCT05969964
- RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 ExpressionRecruitingNCT05957757Phase 2
- Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerRecruitingNCT05951179Phase 2
- HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
- RARC vs LRC in A Multicenter Cohort StudyNot yet recruitingNCT05885204
- Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)RecruitingNCT05879653Phase 2
- Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World StudyNot yet recruitingNCT05856825
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable